Scroll To Top
Issue Features

Do Not Quit Yet

Do Not Quit Yet

Superinfection1_4

Some people on failing anti-HIV drug regimens'as measured through two consecutive viral load tests rising to above 50 copies'may still post CD4-cell increases and avoid AIDS-related illnesses by sticking to their regimens, according to a study in the December 15 issue of Journal of Acquired Immune Deficiency Syndromes. A minority of adults who maintain viral loads below 20,000 copies while sticking to a failing regimen can remain free of clinical disease progression for up to 3H years, according to a study of 25 HIV-positive Chicago adults. Researchers are unclear as to what leads to the continued benefits of the failed regimens but theorize that reduced viral replication capacity and decreased immune activation may play a role. And although some drug resistance was found in most of the study subjects, a majority of the HAART patients with relatively low viral levels responded to at least one drug in two antiretroviral classes.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

Bob Adams

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.